Literature DB >> 22678880

Survey of health status and complications among propionic acidemia patients.

Loren Pena1, Barbara K Burton.   

Abstract

Propionic acidemia (PA) is a rare organic acidemia that is due to deficiency in the enzyme propionyl-coA carboxylase. Complications are currently described mostly in the form of case reports. We sampled a population of affected individuals in order to estimate the frequency of complications amongst the sample. The study is a cross-sectional retrospective review with a survey instrument and recruitment through the Propionic Acidemia Foundation. Responses for 58 individuals were tabulated for each question as how frequently the complication was reported among responders. Commonly reported findings included seizures, arrhythmia, leucopenia, and anemia. Developmental and cognitive disabilities were reported in the majority of individuals. Heart failure or cardiomyopathy was reported in over half of deceased individuals at time of death. Pancreatitis was reported in a minority of the sample, yet more than half of these reported a recurrence. These results update and extend our current knowledge of recognized complications among individuals with PA. The results also provide new information regarding developmental outcomes and previously unreported morbidity from cardiac and gastrointestinal complications. Longitudinal studies exploring associated biochemical and clinical parameters are necessary to further our understanding of the pathophysiology of PA and its complications.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22678880     DOI: 10.1002/ajmg.a.35387

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  19 in total

1.  Biochemical and anaplerotic applications of in vitro models of propionic acidemia and methylmalonic acidemia using patient-derived primary hepatocytes.

Authors:  M Sol Collado; Allison J Armstrong; Matthew Olson; Stephen A Hoang; Nathan Day; Marshall Summar; Kimberly A Chapman; John Reardon; Robert A Figler; Brian R Wamhoff
Journal:  Mol Genet Metab       Date:  2020-05-11       Impact factor: 4.797

Review 2.  Propionyl-CoA carboxylase - A review.

Authors:  Parith Wongkittichote; Nicholas Ah Mew; Kimberly A Chapman
Journal:  Mol Genet Metab       Date:  2017-10-07       Impact factor: 4.797

3.  Effects of adeno-associated virus serotype and tissue-specific expression on circulating biomarkers of propionic acidemia.

Authors:  Adam J Guenzel; Matthew L Hillestad; Dietrich Matern; Michael A Barry
Journal:  Hum Gene Ther       Date:  2014-08-21       Impact factor: 5.695

4.  Gene expression in cell lines from propionic acidemia patients, carrier parents, and controls.

Authors:  Kimberly A Chapman; William S Bush; Zhe Zhang
Journal:  Mol Genet Metab       Date:  2015-05-08       Impact factor: 4.797

5.  Expansion of the Phenotypic Spectrum of Propionic Acidemia with Isolated Elevated Propionylcarnitine.

Authors:  Gerarda Cappuccio; Paldeep S Atwal; Taraka R Donti; Kiki Ugarte; Nadia Merchant; William J Craigen; V Reid Sutton; Sarah H Elsea
Journal:  JIMD Rep       Date:  2016-11-30

6.  Recapitulation of metabolic defects in a model of propionic acidemia using patient-derived primary hepatocytes.

Authors:  Kimberly A Chapman; Maria S Collado; Robert A Figler; Stephen A Hoang; Allison J Armstrong; Wanxing Cui; Michael Purdy; Michael B Simmers; Nada A Yazigi; Marshall L Summar; Brian R Wamhoff; Ajit Dash
Journal:  Mol Genet Metab       Date:  2015-12-24       Impact factor: 4.797

Review 7.  Methylmalonic and propionic acidemias: clinical management update.

Authors:  Jamie L Fraser; Charles P Venditti
Journal:  Curr Opin Pediatr       Date:  2016-12       Impact factor: 2.856

Review 8.  Liver transplantation in propionic and methylmalonic acidemia: A single center study with literature review.

Authors:  Nishitha R Pillai; Bridget M Stroup; Anna Poliner; Linda Rossetti; Brandy Rawls; Brian J Shayota; Claudia Soler-Alfonso; Hari Priya Tunuguntala; John Goss; William Craigen; Fernando Scaglia; V Reid Sutton; Ryan Wallace Himes; Lindsay C Burrage
Journal:  Mol Genet Metab       Date:  2019-11-07       Impact factor: 4.797

9.  Generation of a hypomorphic model of propionic acidemia amenable to gene therapy testing.

Authors:  Adam J Guenzel; Sean E Hofherr; Matthew Hillestad; Mary Barry; Eric Weaver; Sarah Venezia; Jan P Kraus; Dietrich Matern; Michael A Barry
Journal:  Mol Ther       Date:  2013-05-07       Impact factor: 11.454

10.  Dysregulated miRNAs and their pathogenic implications for the neurometabolic disease propionic acidemia.

Authors:  Ana Rivera-Barahona; Alejandro Fulgencio-Covián; Celia Pérez-Cerdá; Ricardo Ramos; Michael A Barry; Magdalena Ugarte; Belén Pérez; Eva Richard; Lourdes R Desviat
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.